KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Travere Therapeutics (TVTX) over the last 13 years, with Q2 2025 value amounting to 0.12.

  • Travere Therapeutics' Debt Ratio changed N/A to 0.12 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.12, marking a year-over-year change of. This contributed to the annual value of 0.12 for FY2024, which is N/A changed from last year.
  • Travere Therapeutics' Debt Ratio amounted to 0.12 in Q2 2025.
  • Over the past 5 years, Travere Therapeutics' Debt Ratio peaked at 0.14 during Q3 2024, and registered a low of 0.01 during Q1 2023.
  • In the last 5 years, Travere Therapeutics' Debt Ratio had a median value of 0.01 in 2022 and averaged 0.05.
  • As far as peak fluctuations go, Travere Therapeutics' Debt Ratio crashed by 6673.64% in 2021, and later skyrocketed by 922.83% in 2022.
  • Over the past 5 years, Travere Therapeutics' Debt Ratio (Quarter) stood at 0.01 in 2021, then rose by 9.23% to 0.01 in 2022, then decreased by 9.97% to 0.01 in 2023, then skyrocketed by 1133.73% to 0.12 in 2024, then rose by 7.24% to 0.12 in 2025.
  • Its Debt Ratio stands at 0.12 for Q2 2025, versus 0.13 for Q1 2025 and 0.12 for Q4 2024.